References
- Castillo-Álvarez F, Hernando de la Bárcena I, Marzo-Sola M. Toxina botulínica en la neuralgia del trigémino[Botulinum toxin in trigeminal neuralgia]. Medicina Clínica. 2017;148(1):28–32.
- Kowacs P, Utiumi M, Nascimento F, et al. OnabotulinumtoxinA for trigeminal neuralgia: a review of the available data. Arquivos de Neuro- Psiquiatria. 2015;73(10):877–884. DOI:10.1590/0004-282X20150109
- Guardiani E, Sadoughi B, Blitzer A, et al. A new treatment paradigm for trigeminal neuralgia using botulinum toxin type A. Laryngoscope. 2013;124(2):413–417.
- Mittal S, Safarpour D, Jabbari B. Botulinum toxin treatment of neuropathic pain. Semin Neurol. 2016;36(1):073–083.
- Rath G. Handbook of trigeminal neuralgia. Singapore, Singapore: Springer; 2019.
- Burmeister J, Holle D, Bock E, et al. Botulinum neurotoxin type A in the treatment of classical trigeminal neuralgia (BoTN): study protocol for a randomized controlled trial. Trials. 2015;16:550.
- Tepper S. Cranial neuralgias. Continuum: lifelong learning in neurology. Headache. 2018;24(4):1157–1178.
- Morra M, Elgebaly A, Elmaraezy A, et al. Therapeutic efficacy and safety of botulinum toxin A therapy in trigeminal neuralgia: a systematic review and meta-analysis of randomized controlled trials. J Headache Pain. 2016;17(1):63. DOI:10.1186/s10194-016-0651-8.
- Meng F, Peng K, Yang J, et al. Botulinum toxin-A for the treatment of neuralgia: a systematic review and meta-analysis. J Pain Res. 2018;11:2343–2351.
- Park J, Park H. Botulinum toxin for the treatment of neuropathic pain. Toxins (Basel). 2017;9(9):260.
- Crespi J, Bratbak D, Dodick D, et al. Pilot study of injection of OnabotulinumtoxinA toward the sphenopalatine ganglion for the treatment of classical trigeminal neuralgia. Headache. 2019;59(8):1229–1239. DOI:10.1111/head.13608.
- Liu J, Xu Y, Zhang Q, et al. Efficacy and safety of botulinum toxin type A in treating patients of advanced age with idiopathic trigeminal neuralgia. Pain Res Manag. 2018;2018:1–5.
- Lenaerts M, Green T. OnabotulinumtoxinA in migraine and other headaches: review and update. Curr Treat Options Neurol. 2019;21(4):21.
- Fischoff D, Spivakovsky S. Botulinum toxin for facial neuralgia. Evid Based Dent. 2018;19(2):57–58.
- Li S, Lian Y, Chen Y, et al. Therapeutic effect of botulinum toxin-A in 88 patients with trigeminal neuralgia with 14-month follow- up. J Headache Pain. 2014;15(1):43. DOI:10.1186/1129-2377-15-43.
- Nathan N, Dieb W, Descroix V, et al. Topical review: potential use of botulinum toxin in the management of painful posttraumatic trigeminal neuropathy. J Oral Facial Pain Headache. 2017;31(1):7–18. DOI:10.11607/ofph.1753.
- Shackleton T, Saravanen R, Black M, et al. The efficacy of botulinum toxin for the treatment of trigeminal and postherpetic neuralgia: a systematic review with meta-analyses. Br Dent J. 2016;221(8):475.
- Wu C, Xie N, Liu H, et al. A new target for the treatment of trigeminal neuralgia with botulinum toxin type A. Neurol Sci. 2018;39(3):599–602. DOI:10.1007/s10072-017-3171-7.
- Xia J, He C, Zhang H, et al. Botulinum toxin A in the treatment of trigeminal neuralgia. Int J Neurosci. 2016;126(4):348–353. DOI:10.3109/00207454.2015.1019624.
- Yang K, Kim M, Ju J, et al. Antinociceptive effects of botulinum toxin type A on trigeminal neuropathic pain. J Dent Res. 2016;95(10):1183–1190. DOI:10.1177/0022034516659278.
- Zhang H, Lian Y, Xie N, et al. Single-dose botulinum toxin type A compared with repeated-dose for treatment of trigeminal neuralgia: a pilot study. J Headache Pain. 2017;18(1):81.